FDA’s Predetermined Change Control Plan (PCCP): Powering Safe Innovation In AI-Enabled Medical Devices

Artificial Intelligence (AI) is transforming healthcare from diagnostic imaging to continuous patient monitoring and clinical decision support. However, AI-based medical devices require frequent updates and algorithm improvements, which create regulatory challenges.

To address this, the U.S. Food and Drug Administration introduced the Predetermined Change Control Plan (PCCP) in December 2024, enabling manufacturers to implement pre-approved software changes without repeated submissions, while maintaining safety and compliance.

What is FDA PCCP?

A Predetermined Change Control Plan (PCCP) is an FDA-reviewed regulatory framework that allows manufacturers of AI-enabled medical devices to implement predefined software updates without submitting a new application, provided the changes follow an approved plan ensuring safety and effectiveness.

Why PCCP Matters for AI Medical Devices

• AI models continuously evolve with new data 
• Traditional regulatory pathways require re-submission for changes 
• PCCP enables controlled, lifecycle-based innovation 
• Balances innovation speed with patient safety 

What is PCCP?

A PCCP is a pre-submitted, FDA-reviewed plan included in a device application that outlines how AI software will be modified, validated, and maintained post-approval.

Key Objective

Move from static approvals → continuous lifecycle oversight

Three Core Components of a PCCP

1. Description of Planned Changes

Defines:

• Type of anticipated algorithm updates 
• Scope of modifications 
• Alignment with intended use 

Purpose

Ensures all changes are predictable, transparent, and controlled

2. Modification Plan

Outlines how updates will be:

• Developed 
• Tested and validated 
• Implemented safely 

Includes

• Data management and input controls 
• Algorithm retraining methodology 
• Performance evaluation metrics 

3. Impact Assessment

Evaluates:

• Risk vs benefit of changes 
• Impact on device safety and performance 
• Mitigation strategies 

PCCP Component Overview

Scope: Who Should Use PCCPs?

Applicable To

• AI-enabled Software as a Medical Device (SaMD) 
• Machine learning-based diagnostic tools 
• Adaptive clinical decision systems 

Not Applicable To

• Drugs or biologics 
• Non-AI traditional medical devices 

Submission Timing

• Included in initial regulatory submission 
• Reviewed during premarket approval or clearance 

Why PCCPs Are Critical

1. Faster Innovation

• Eliminates repeated regulatory submissions 
• Enables continuous AI improvement 

2. Regulatory Clarity

• Predefined framework for updates 
• Reduces uncertainty for manufacturers 

3. Patient Safety

• Ensures all changes are validated and risk-assessed 

4. Market Agility

• Rapid response to: 
  • New clinical data 
  • Emerging risks 
  • Technological advancements 

5. Transparency

• Updated labeling and documentation 
• Clear communication to healthcare providers 

Traditional vs PCCP Approach

Best Practices for PCCP Implementation

1. Early Regulatory Engagement

Use FDA’s Q-Submission Program to:

• Discuss PCCP strategy 
• Align expectations early 

2. Strong Quality Management System

Align with:

• ISO 13485 
• FDA Quality System Regulation (QSR) 

Focus Areas

• Design controls 
• Change management 
• Version control 

3. Data Governance & AI Validation

Ensure:

• High-quality training datasets 
• Bias mitigation 
• Reproducibility of results 
• Robust validation protocols 

4. Labeling and Transparency

• Update device labeling with approved changes 
• Communicate clearly with users and clinicians 

Challenges in PCCP Implementation

• Defining acceptable scope of changes 
• Managing algorithm drift 
• Ensuring consistent validation standards 
• Maintaining detailed documentation 
• Cross-functional coordination (AI, regulatory, QA) 

Key Challenges & Solutions

Future of AI Regulation in Healthcare

PCCPs reflect a major regulatory shift toward adaptive, lifecycle-based oversight.

Emerging Trends

• Continuous learning AI systems 
• Global harmonization of AI regulations 
• Increased use of real-world performance monitoring 
• Integration of digital health ecosystems 

Regulatory Expertise in AI Medical Devices

Maven Regulatory Solutions provides specialized regulatory strategies for AI-enabled medical devices, ensuring compliance with evolving FDA frameworks like PCCP.

Global Digital Health Experience

Our expertise spans:

• Software as a Medical Device (SaMD) 
• AI/ML regulatory pathways 
• Global digital health compliance 

Technical and Scientific Authority

Our team includes:

• AI regulatory specialists 
• Quality and validation experts 
• Clinical and safety professionals 

Trust Through Compliance and Innovation

We assure you:

• Safe and Compliant AI updates 
• Transparent lifecycle management 
• Regulatory readiness 
• Long-term product success 

Build Your PCCP Strategy

Partner with Maven Regulatory Solutions

Developing AI-enabled medical devices?

We will help you.

• Design FDA-compliant PCCPs 
• Navigate AI regulatory pathways 
• Implement robust validation frameworks 
• Ensure lifecycle compliance 

Our Services

• PCCP strategy development 
• Regulatory submission support 
• AI validation and compliance 
• Quality system implementation 
• Post-market lifecycle management 

Why Choose Maven

• Deep expertise in FDA AI regulations 
• End-to-end regulatory support 
• Advanced digital health knowledge 
• Proven compliance strategies 

Conclusion

The FDA’s PCCP framework marks a turning point in AI medical device regulation, enabling continuous innovation without compromising safety.

By adopting PCCPs, companies can:

• Accelerate innovation 
• Maintain compliance 
• Enhance patient safety 
• Stay competitive in digital health 

FAQs 

1. What is PCCP?

A plan allowing pre-approved AI updates without new submissions.

2. When was PCCP introduced?

December 2024.

3. Does PCCP apply to all medical products?

No, only AI-enabled medical devices.

4. What are its main components?

Description of changes, modification plan, and impact assessment.

5. Why is PCCP important?

It enables faster innovation with regulatory compliance.

6. Is FDA approval still required?

Yes, PCCP is reviewed during initial submission.

7. How can Maven help?

By designing and implementing compliant PCCP strategies.